Nevertheless, loss-of-function mutations and genomic modifications in the IFN-γ signaling pathway and antigen presentation signaling pathway result in cancer immune evasion, and IFN-γ may promote tumor antigen loss and induce tumor immune editing, resulting in tumor progression and recurrence (49, 65, 110). This evidence concerns the gene IFNG and cancer.